🇺🇸 FDA
Patent

US 11452775

Detection of arginine methylation of EGFR for prediction of resistance to therapy

granted A61KA61K2039/505A61K31/7076

Quick answer

US patent 11452775 (Detection of arginine methylation of EGFR for prediction of resistance to therapy) held by The Board of Regents of the University of Texas System expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K31/7076, A61K38/19, A61K39/39558